| parent | Antitubercular agents | LP31463-0 |
| child | Pyrazinamide 25.0 ug/mL | LP229451-2 |
| child | Pyrazinamide | Isolate | Antibiotic susceptibilities | LP380407-9 |
| child | Pyrazinamide | Isolate and Serum | Antibiotic susceptibilities | LP380409-5 |
| child | Pyrazinamide 100.0 ug/mL | LP229449-6 |
| child | Pyrazinamide 200.0 ug/mL | LP229450-4 |
| child | Pyrazinamide 300.0 ug/mL | LP229452-0 |
| parent | Antitubercular agents | LP31463-0 |
| child | Pyrazinamide | Serum or Plasma | Drug toxicology | LP389128-2 |
| child | Pyrazinamide | XXX | Drug toxicology | LP389129-0 |
| PartDisplayName | en-US | Pyrazinamide |
| DisplayName | en-US | Pyrazinamide |
LOINC Version: 2.80
FHIR